Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Johnson

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Cell|October 1, 1983
A mouse model for beta-thalassemiaL C Skow, B A Burkhart, F M Johnson, et al.
Oncogene|April 19, 2016
Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitorsS-C Lee, H-Y Min, H J Jung, et al.
Oncogene|February 16, 2010
Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cellsL Xu, M B Nilsson, P Saintigny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinomaR I Haddad, E Massarelli, J J Lee, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targetingP Yadollahi, K A McCord, Y Li, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Cell|October 1, 1983
A mouse model for beta-thalassemiaL C Skow, B A Burkhart, F M Johnson, et al.
Oncogene|April 19, 2016
Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitorsS-C Lee, H-Y Min, H J Jung, et al.
Oncogene|February 16, 2010
Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cellsL Xu, M B Nilsson, P Saintigny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinomaR I Haddad, E Massarelli, J J Lee, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targetingP Yadollahi, K A McCord, Y Li, et al.
Pageof 7